PacRoots Cannabis

Leveraging the Economics of Genetics

This PacRoots Cannabis profile is part of a paid investor education campaign.*


PacRoots Cannabis (CSE:PACR) is a British Columbia-based Cannabis Act licensed applicant dedicated to producing premium-quality cannabis products based on high-end selectively bred genetics. By focusing on high-end genetics, the company can maximize the quality of its products while keeping yields and profit margins high.

Through the process of artificial selection, farmers and cultivators have been adapting their plants to develop particular phenotypic traits for thousands of years. Previously, this breeding has been restricted to underground cannabis producers creating their own strains in private. The legalization of the cannabis industry, however, has allowed producers to work in the open with access to thousands of cultivars from all over the world to truly get the most out of cannabis genetics. By carefully selecting cannabis genetics, growers can control the size, color, smell, density and texture of their cannabis buds, creating a unique premium cannabis experience. Plants can be bred specifically to thrive within their unique growing environments, producing large yields of high-quality resilient cannabis. Medical cannabis strains can also be tailored for specific medical purposes.

PacRoots has formed a strategic partnership with Phenome One to give the company access to some of the world’s best cannabis genetics from the largest genetic library in Canada. The company is using these genetics to develop unique strains with various beneficial characteristics. The company’s 350 licensed cultivars are the result of a meticulous gene selection process, in which as many as 600 individual plants may be grown to produce a single strain. To develop a unique strain, plants with the desired traits are grown and the ones that don’t exhibit the traits well enough are discarded. The remaining plants are bred repeatedly, resulting in a customized cannabis strain after several generations of optimization.

The economics of genetics

Using optimally selected genetics comes with benefits that go beyond simply producing a high-end product. In addition to potency and bud quality, cannabis plants are bred for yield and resilience. By selecting genetics that result in larger and more numerous buds on each plant, PacRoots is able to grow more cannabis per grow light. Breeding plants to be more resilient lowers the cost and labor intensity of the grow. Genetics can be selected to grow plants that will thrive within the conditions of their specific growing climate. These factors, combined with the premium price point that comes with top-quality cannabis, have the potential to improve overall profit margin.

pac roots banner image

PacRoots’ Company Highlights

  • Genetics-focused approach to cannabis cultivation
  • Access to 350 unique cultivars through a genetics licensing partnership with Phenome One
  • 20,000 square foot cultivation facility in Lake Country, British Columbia
  • Cultivation license expected in the third quarter of 2020

PacRoots’ Lake Country cultivation facility

PacRoots is nearing completion of its 20,000 square foot cultivation facility in Lake Country, British Columbia and is currently in the process of acquiring its cultivation license. The facility will feature approximately 7,600 square feet of cultivation space set up for the company to cycle through an elite line of high-grade cultivars. PacRoots also plans to submit a video evidence package of its facility build under Health Canada’s Cannabis Tracking and Licensing System and the company expects to acquire its license by the end of the third quarter of 2020.

render of pacroots facility

Render of the PacRoots Kelowna facility

Lake Country is a municipality located just outside of Kelowna in the Okanagan region of British Columbia. For decades, the region’s favorable growing climate has made it a hub for cannabis cultivation. As the Canadian legal cannabis industry ramps up, the Okanagan is attracting investment from dozens of cannabis companies, including some of the industry’s biggest names. The region’s strong agricultural history means there is no shortage of experienced agricultural workers and an abundance of ALR land.

pacific roots facility

Genetics licensing partnership with Phenome One

PacRoots has secured its cultivars through a strategic licensing agreement with Phenome One. The agreement gives PacRoots unlimited access to Phenome’s live genetic library, including any of Phenome’s cultivars as well as it’s growing, breeding and cloning IP. Phenome One is an agricultural technology company focused on providing software solutions to seed companies. Phenome One’s platform gives its partners access to a massive database of detailed information on 350 unique cannabis cultivars to support each stage of the breeding process. Each cultivar has been laboratory analyzed and rigorously field-tested with data going back more than 30 years.

Using Phenome’s data, PacRoots plans to grow a range of cannabis plants optimized for a variety of traits, including plants with an abundance of cannaflavin, a rare terpene with high anti-inflammatory properties. Phenome’s library could enable PacRoots to produce plants that are optimized to thrive in a range of different growing climates, including plants suited to grow in cold weather and plants that are resilient to region-specific fungi.

PacRoots’ Management Team

Patrick Elliott, MSC, MBA—President and CEO

Mr. Elliott is a true leader and entrepreneur. He is the President & CEO of Lexore Capital Corp., a private resource and cannabis investment company as well as Phenome One Corp, a full-service cannabis farming company focused on elite strain selective breeding. Mr. Elliott brings over 10 years of corporate finance, mineral exploration and financial markets experience. He is a graduate of the University of Western Ontario in Geology and holds an MSc. in Mineral Economics and an MBA from Curtin University of Technology in Perth, Australia. Patrick specializes in economic resource evaluation, financial modeling, CAPEX estimation, corporate development and finance. Combined with his technical knowledge, Patrick has a wealth of contacts in the financial sector.

Marc Geen—Founder and Director

Mr. Geen is currently CEO of Speakeasy Cannabis Club focused on building an unprecedented indoor, outdoor and greenhouse program on a 290-acre prime agricultural parcel in Rock Creek, BC. A proud 4th-generation BC farmer, Marc Geen has been active in the legal medical marijuana industry for more than 10 years, consulting, complying with, and participating in the MMAR, MMPR, and ACMPR programs. Prior to co-founding Speakeasy Cannabis Club Ltd, Marc spent 14 years as Head of Operations for Kettle Mountain Ginseng Ltd, one of North America’s largest ginseng producers. The experience gleaned from a long career in large scale commercial farming, Mr. Geen has been able to apply many cost-effective, good farming practices to the outdoor, indoor, and greenhouse cultivation of cannabis. Mr. Geen is also the co-creator of a full line of cannabis extract products designed under ACMPR regulations.

Matt McGill—Director

Mr. McGill has a strong background in both commercial and residential real estate and has played a major role in many development projects. Matt and McGill Realty have established a tremendous commercial and residential outfit servicing the Fraser Valley and the lower mainland. Matt is skilled at crafting strategic financing options for corporations and he has a substantial network of retail and institutional clients. Mr. McGill is also an integral part of restaurant/hospitality ventures with several chains of restaurants in the lower mainland. He also serves as a Director on a number of non-profit associations. Mr. McGill is an entrepreneur and financial strategist who brings a wealth of knowledge and experience to the team at Pac Roots.

Josh Bromley—Senior Cultivation Strategist

Josh has grown up in British Columbia’s thriving cannabis industry. As a second-generation farmer, Josh has over 2 decades of experience farming, breeding, cultivating and selecting unique cultivars for the medical community. He is an expert in plant science and possesses a comprehensive knowledge of cultivars and a mastery of medicinal implementation. Previously, he has developed proprietary farming systems, as well as low cost/ high output nutrient systems. Through thoughtful design and engineering, he has been able to consistently show improvements in crop yields, pathogen resiliency and quality. Currently, he is the COO and Director of Phenome One Corp. Josh also continues to select, test and collect unique genetics for Phenome One.

Dom Stann—Marketing Executive

Dominic Stann is a technology entrepreneur with over 15 years of diverse experience specializing in communications, design, affiliate marketing, marketing and brand creation. As his career has evolved, he has been involved in the successful business development of technology solutions for start-ups and early-stage ventures.

William Fleming—Director

Mr. Fleming has founded and served as CEO for a number of entrepreneurial companies and has served with senior executive teams dealing with equity and debt financings. Mr. Fleming has developed corporate strategies for a wide range of companies, from family-owned businesses to multi-national companies. Bill currently serves as President of Mernova Medicinal Inc., which recently sold to Switzerland based Creso Pharma Limited. Mr. Fleming is the Executive Chairman of Mountain Lake Minerals and was the CEO and Director of Abattis Bioceuticals Corp. He most recently served as the CFO and Director of NWest Energy Corp. Mr. Fleming has experience in raising equity for small-cap companies and has experience in mineral exploration, renewable energy and the cannabis industry.

Chad Clelland—Director

Mr. Clelland’s experience in the sector dates back to 2009 when he purchased which became an information portal for thousands of patients, doctors and growers. Through this company he and his team have helped thousands of Canadians find legal, safe medication. His team also consulted, designed and submitted dozens of applications to the government under the MMPR, ACMPR and Cannabis Act. In 2011, Mr. Clelland also co-founded Greenleaf Medical Clinic; now recognized as a training facility by the University of British Columbia and offers preceptorships to physicians, nurse practitioners and pharmacists. He also co-founded Folium Life Science in 2013, an approved Canadian Licensed Producer. His roles in these organizations have included Chief Operating Officer, head of security, alternate master grower and alternate responsible person in charge.


*Disclaimer: This profile is sponsored by PacRoots Cannabis. This profile provides information which was sourced by the Investing News Network (INN) and approved by PacRoots Cannabis, in order to help investors learn more about the company. PacRoots Cannabis is a client of INN. The company’s campaign fees pay for INN to create and update this profile.

INN does not provide investment advice and the information on this profile should not be considered a recommendation to buy or sell any security. INN does not endorse or recommend the business, products, services or securities of any company profiled.

The information contained here is for information purposes only and is not to be construed as an offer or solicitation for the sale or purchase of securities. Readers should conduct their own research for all information publicly available concerning the company. Prior to making any investment decision, it is recommended that readers consult directly with PacRoots Cannabis and seek advice from a qualified investment advisor.